Heinzerling is among the researchers whose studies are vetted by the Research Advisory Panel of California. California lawmakers could soon clear a governmental logjam that has held up dozens of studies related to addiction treatment, psychedelics or other federally restricted drugs. “We are focused on reactivating the large amount of research studies that have been on hold for over a year now,” Waldron said in a statement. Because other states don’t have that hurdle, they argued, California researchers are losing out on competitive funding — and Californians miss chances to participate in local trials for emerging treatments. UCLA psychologist and addiction researcher Steven Shoptaw called it “an unequal burden on addiction research” compared with other scientific studies.

Source: Los Angeles Times May 07, 2024 18:07 UTC